This study examines the value of stem cell transplantation in managing light chain amyloidisis.
1. How does age at diagnosis affect prognosis in primary amyloidosis? 2. How do lab values at diagnosis such as Creatinine, AST/ALT, total serum protein, serum gamma globulin/immunoglobulin levels affect prognosis in primary amyloidosis? 3. How does degree of organ involvement/number of organs involved affect prognosis in primary amyloidosis? 4. How does initial treatment affect prognosis in primary amyloidosis? 4\. How do the specifics the stem cell transplant protocol affect prognosis in primary amyloidosis?
Study Type
OBSERVATIONAL
Enrollment
400
Mayo Clinic
Rochester, Minnesota, United States
Survival
Time frame: up to 8 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.